The Harvard Crimson

FDA Approves New Drug for Treating Most Common Type of Lung Cancer, Based on Broad Institute Research

The Food and Drug Administration granted accelerated approval on Wednesday for a new drug developed by researchers at the ...

US FDA approves Novartis' gene therapy for rare muscle disorder

The U.S. Food and Drug Administration has approved Novartis' gene therapy for patients with a rare muscle disorder, the drugmaker said on Monday.
CURE

How New Therapies Are Changing the Game for Small Cell Lung Cancer

Dr. Charles M. Rudin highlighted new small cell lung cancer therapies, including T cell engagers, antibody-drug conjugates, ...
Managed Healthcare Executive

How health systems can integrate tobacco-cessation interventions for HIV, tuberculosis patients

Integrating tobacco-cessation services into HIV and tuberculosis care can enhance treatment outcomes and reduce mortality. Health systems should implement comprehensive tobacco-cessation strategies, ...